drugset / Trial / NCT00554385
A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in children with ADHD.
Timeline
- Start
- 2007-11
- Primary completion
- 2008-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pozanicline | Small molecule | 1 mg | — |
| Subject | Pozanicline | Small molecule | 5 mg | — |
| Subject | Pozanicline | Small molecule | 10 mg | — |
| Subject | Pozanicline | Small molecule | 40 mg | — |
| Subject | Pozanicline | Small molecule | 80 mg | — |